Mesenchymal stromal cells of myelodysplastic syndrome and acute myeloid leukemia patients have distinct genetic abnormalities compared with leukemic blasts

High Cytogenetic or Molecular Genetic Risk Acute Myeloid Leukemia

(2011) E. Estey   Hematology-American Society of Hematology Education Program

Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials

(2010) D. Grimwade et al.   BLOOD

Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia

(2010) Marc H. G. P. Raaijmakers et al.   NATURE

Molecular diagnostics in acute leukemias

(2009) Ulrike Bacher et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Therapeutic targeting of microenvironmental interactions in leukemia: Mechanisms and approaches

(2009) Marina Konopleva et al.   DRUG RESISTANCE UPDATES

Both expanded and uncultured mesenchymal stem cells from MDS patients are genomically abnormal, showing a specific genetic profile for the 5q− syndrome

(2009) O Lopez-Villar et al.   LEUKEMIA

Reserves, Functional, Immunoregulatory, and Cytogenetic Properties of Bone Marrow Mesenchymal Stem Cells in Patients with Myelodysplastic Syndromes

(2009) Mirjam Klaus et al.   STEM CELLS AND DEVELOPMENT

Molecular pathways in myelodysplastic syndromes and acute myeloid leukemia: relationships and distinctions-a review

(2008) Paolo Bernasconi   BRITISH JOURNAL OF HAEMATOLOGY

A novel role for the marrow microenvironment in initiating and sustaining hematopoietic disease

(2008) Aravind Ramakrishnan et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Functional analysis of myelodysplastic syndromes-derived mesenchymal stem cells

(2008) Eugenia Flores-Figueroa et al.   LEUKEMIA RESEARCH

Prognostic Implications of Gene Mutations in Acute Myeloid Leukemia With Normal Cytogenetics

(2008) Verena Gaidzik et al.   SEMINARS IN ONCOLOGY